Organisations facing high-stakes scientific and technical decisions.
Expertia works with organisations that cannot afford to decide without high-level, independent, rigorous and confidential expertise.
Biotech, Pharma, Medtech & Healthtech
Companies developing therapies, devices and health technologies face scientific decisions of exceptional complexity — often under tight timelines and regulatory constraints.
Submit a request- Structure or redirect an R&D programme
- Validate a scientific hypothesis
- Prepare a fundraising or acquisition
- Evaluate preclinical or clinical results
- Valorise a scientific asset
- Establish a Scientific Advisory Board
VC, Private Equity, Family Offices & Investors
An investment decision in a biotech, deeptech or AI company rests on scientific and technical assumptions that must be examined independently — before and after the transaction.
Prepare a due diligence- Evaluate the robustness of the scientific foundation
- Identify technical risks before the transaction
- Challenge the credibility of the scientific team
- Understand actual technology maturity
- Secure a portfolio position
- Prepare an exit on scientific assets
M&A boutiques, investment banks & fundraising advisors
Transactions involving scientific or technological assets require an independent perspective that goes beyond financial projections — to protect stakeholders and secure the credibility of the file.
Discuss a mandate- Bring scientific expertise on a white-label basis
- Identify technical red flags before a transaction
- Prepare data rooms on scientific assets
- Qualify scientific management questions
- Structure the scientific narrative for a fundraising
- Secure a sell-side or buy-side review
Deeptech, AI & advanced technologies
Companies developing deep technologies — AI models, advanced systems, data platforms — face decisions where scientific and technical rigour determines credibility and value.
Submit a request- Define and structure an AI or deeptech roadmap
- Challenge a technical architecture or approach
- Validate results and assess reproducibility
- Prepare a fundraising or acquisition on technological assets
- Evaluate software, data or algorithmic assets
- Identify robustness, bias or security risks
Institutions, governments, tech transfer offices & universities
Public and research organisations need independent expertise to evaluate programmes, valorise results and inform decisions with significant social or economic impact.
Discuss a programme- Evaluate a research or innovation programme
- Structure valorisation and technology transfer
- Constitute an independent scientific jury or committee
- Identify scientific funding levers
- Prepare a grant application response
- Review results before public communication
Media, producers, museums & educational organisations
The scientific credibility of content — documentary, exhibition, publication, educational programme — depends on the rigour of the review that precedes it. Expertia provides this independent expertise.
Have content reviewed- Validate the scientific content of a documentary or series
- Review scripts, popular science texts or educational content
- Provide scientific review for an exhibition
- Substantiate claims in corporate communication
- Verify sources and data before publication
- Support the production of immersive or educational content